Assenagon Asset Management S.A. Purchases 75,567 Shares of Axon Enterprise, Inc $AXON

Assenagon Asset Management S.A. boosted its position in shares of Axon Enterprise, Inc (NASDAQ:AXONFree Report) by 57.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 207,429 shares of the biotechnology company’s stock after acquiring an additional 75,567 shares during the period. Assenagon Asset Management S.A. owned 0.26% of Axon Enterprise worth $117,805,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of AXON. Stone House Investment Management LLC purchased a new stake in Axon Enterprise during the 3rd quarter worth approximately $29,000. New Millennium Group LLC purchased a new position in shares of Axon Enterprise in the third quarter worth $29,000. Darwin Wealth Management LLC purchased a new position in shares of Axon Enterprise in the second quarter worth $37,000. Root Financial Partners LLC acquired a new stake in shares of Axon Enterprise during the third quarter worth $34,000. Finally, Elevation Point Wealth Partners LLC purchased a new stake in shares of Axon Enterprise during the second quarter valued at $56,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise News Summary

Here are the key news stories impacting Axon Enterprise this week:

Axon Enterprise Price Performance

Shares of AXON opened at $507.28 on Tuesday. The business’s 50-day moving average is $516.98 and its two-hundred day moving average is $597.88. The company has a market capitalization of $40.79 billion, a P/E ratio of 333.74, a P/E/G ratio of 10.59 and a beta of 1.46. Axon Enterprise, Inc has a fifty-two week low of $396.41 and a fifty-two week high of $885.91. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.29 and a current ratio of 2.53.

Axon Enterprise (NASDAQ:AXONGet Free Report) last issued its quarterly earnings data on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.60 by $0.55. The business had revenue of $796.72 million during the quarter, compared to analysts’ expectations of $755.29 million. Axon Enterprise had a return on equity of 2.82% and a net margin of 4.48%.The company’s revenue for the quarter was up 38.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.08 EPS. Research analysts predict that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Jeri Williams sold 157 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $490.00, for a total transaction of $76,930.00. Following the completion of the transaction, the director directly owned 1,159 shares of the company’s stock, valued at $567,910. The trade was a 11.93% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction on Wednesday, February 25th. The shares were sold at an average price of $500.24, for a total transaction of $5,002,400.00. Following the completion of the transaction, the chief executive officer owned 3,090,997 shares of the company’s stock, valued at approximately $1,546,240,339.28. This represents a 0.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 23,855 shares of company stock valued at $13,299,928 in the last three months. 5.70% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. William Blair reissued an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 3rd. Royal Bank Of Canada dropped their price target on Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 25th. Barclays cut their price objective on Axon Enterprise from $702.00 to $682.00 and set an “overweight” rating on the stock in a report on Wednesday, February 25th. Morgan Stanley reduced their price objective on Axon Enterprise from $713.00 to $675.00 and set an “overweight” rating for the company in a research note on Wednesday, February 25th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axon Enterprise in a report on Monday, December 29th. Sixteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average price target of $762.93.

View Our Latest Research Report on Axon Enterprise

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.

Featured Articles

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.